Very strong statistical significance. 3 weeks until first read out of phase 1 cohort. 18 million market cap on a 60 billion dollar unmet market and the only drug in the world to have this type of effectiveness in secondary brain injury preclinically
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22143 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 10.17am 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable